HCPCS Code Descriptor:
Injection, paclitaxel protein-bound particles, 1 mg
Route of Administration:
ABRAXANE is an Oncology drug manufactured by Celgene and administered via the Intravenous route of administration. The J Code: J9264 is aligned to the drug ABRAXANE.